Arthur H. Tatum

2.1k total citations
50 papers, 1.7k citations indexed

About

Arthur H. Tatum is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arthur H. Tatum has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arthur H. Tatum's work include Lung Cancer Research Studies (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Glycosylation and Glycoproteins Research (6 papers). Arthur H. Tatum is often cited by papers focused on Lung Cancer Research Studies (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Glycosylation and Glycoproteins Research (6 papers). Arthur H. Tatum collaborates with scholars based in United States, Italy and Canada. Arthur H. Tatum's co-authors include Stephen L. Graziano, Leonard H. Sigal, Robert B. Jennings, Keith A. Reimer, Nancy Newman, David C. Haas, Albert Oler, András Perl, Katalin Bánki and Emanuela Colombo and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Arthur H. Tatum

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur H. Tatum United States 24 448 433 356 298 280 50 1.7k
Hideo Takeshima Japan 25 248 0.6× 765 1.8× 511 1.4× 207 0.7× 317 1.1× 123 2.3k
I G Rennie United Kingdom 29 680 1.5× 831 1.9× 254 0.7× 331 1.1× 186 0.7× 136 2.8k
Anna Brunn Germany 28 281 0.6× 393 0.9× 799 2.2× 285 1.0× 316 1.1× 84 2.0k
Gian Luigi Taddei Italy 26 488 1.1× 595 1.4× 181 0.5× 205 0.7× 321 1.1× 136 2.3k
R Rampling United Kingdom 23 810 1.8× 778 1.8× 477 1.3× 151 0.5× 372 1.3× 49 2.7k
Toru Nishi Japan 25 226 0.5× 750 1.7× 572 1.6× 247 0.8× 236 0.8× 70 2.0k
Chi Chao Chan United States 22 336 0.8× 240 0.6× 278 0.8× 196 0.7× 130 0.5× 38 1.6k
Ryuhei Kitai Japan 21 198 0.4× 374 0.9× 351 1.0× 93 0.3× 277 1.0× 100 1.4k
Barry S. Wilson United States 25 569 1.3× 899 2.1× 297 0.8× 656 2.2× 178 0.6× 55 2.6k
Hetty L. DeVroom United States 19 382 0.9× 613 1.4× 425 1.2× 106 0.4× 125 0.4× 25 2.6k

Countries citing papers authored by Arthur H. Tatum

Since Specialization
Citations

This map shows the geographic impact of Arthur H. Tatum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur H. Tatum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur H. Tatum more than expected).

Fields of papers citing papers by Arthur H. Tatum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur H. Tatum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur H. Tatum. The network helps show where Arthur H. Tatum may publish in the future.

Co-authorship network of co-authors of Arthur H. Tatum

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur H. Tatum. A scholar is included among the top collaborators of Arthur H. Tatum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur H. Tatum. Arthur H. Tatum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graziano, Stephen L., Lin Gu, Xiaofei Wang, et al.. (2010). Prognostic Significance of Mucin and p53 Expression in Stage IB Non-small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633. Journal of Thoracic Oncology. 5(6). 810–817. 22 indexed citations
2.
Gajra, Ajeet, Arthur H. Tatum, Nancy Newman, et al.. (2002). The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer. Lung Cancer. 36(2). 159–165. 36 indexed citations
3.
Graziano, Stephen L., Arthur H. Tatum, James E. Herndon, et al.. (2001). Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study. Lung Cancer. 33(2-3). 115–123. 50 indexed citations
4.
Mehdi, Syed A., Arthur H. Tatum, Nancy Newman, et al.. (1999). Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up. Clinical Lung Cancer. 1(1). 59–67. 26 indexed citations
5.
Davis, Richard L., P D Holohan, Antony E. Shrimpton, et al.. (1999). Familial Encephalopathy with Neuroserpin Inclusion Bodies. American Journal Of Pathology. 155(6). 1901–1913. 87 indexed citations
6.
Graziano, Stephen L., Jeffrey A. Kern, James E. Herndon, et al.. (1998). Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: A Cancer and Leukemia Group B study. Lung Cancer. 21(3). 203–211. 25 indexed citations
8.
Mehdi, Syed A., et al.. (1998). Prognostic Significance of Lewis y Antigen in Resected Stage I and II Non-small Cell Lung Cancer. CHEST Journal. 114(5). 1309–1315. 13 indexed citations
9.
Breuer, Brenda, Immaculata De Vivo, Steven J. Smith, et al.. (1994). erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients.. PubMed. 3(1). 63–6. 24 indexed citations
10.
Friedman, Henry D., Nick J. Gonchoroff, David Jones, & Arthur H. Tatum. (1994). Pleomorphic fibrohistiocytoma of the breast: a potential pitfall in breast biopsy interpretation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 425(2). 199–203. 6 indexed citations
12.
Bánki, Katalin, Emanuela Colombo, David L. Halladay, et al.. (1994). Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.. The Journal of Experimental Medicine. 180(5). 1649–1663. 119 indexed citations
13.
Tatum, Arthur H.. (1993). Large scale recovery of biologically active IgM (95% pure) from human plasma obtained by therapeutic plasmapheresis. Journal of Immunological Methods. 158(1). 1–4. 17 indexed citations
14.
Baird, Andrew, et al.. (1992). Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms.. PubMed. 5(3). 303–7. 42 indexed citations
15.
Scheinman, Steven J., et al.. (1991). Case Report: Hypercalcemia with Excess Serum 1,25 Dihydroxyvitamin D in Lymphomatoid Granulomatosis/Angiocentric Lymphoma. The American Journal of the Medical Sciences. 301(3). 178–181. 16 indexed citations
16.
Krauss, Dennis J., et al.. (1991). Metastatic carcinoma of prostate 23 years after radical prostatectomy. Urology. 37(5). 470–471. 1 indexed citations
17.
Graziano, Stephen L., Nancy Newman, Arthur H. Tatum, et al.. (1989). The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.. Journal of Clinical Oncology. 7(10). 1398–1406. 157 indexed citations
18.
Kolbeck, Peter C., Arthur H. Tatum, & Fred Sanfilippo. (1985). Phenotypic evaluation of mononuclear cell infiltrates in renal allograft biopsies. Transplantation Proceedings. 17. 893–895. 3 indexed citations
19.
Martinez, Salutario, et al.. (1985). Case report 330. Skeletal Radiology. 14(2). 157–157. 1 indexed citations
20.
Tatum, Arthur H., John D. Shelburne, Peter Ingram, et al.. (1983). Scanning electron microscopy and X-ray microanalysis of foreign bodies associated with silastic implants in humans. Contraception. 28(6). 543–552. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026